Not himself/herself after Lokivetmab (Cytopoint) in dogs

84 reports to the FDA describe not himself/herself in dogs given Lokivetmab. That is 1.3% of all reports for this medicine, compared with 0.3% across reports for all dog medicines, so it is reported unusually often with this medicine.

84Reports

71%Marked serious

13%Recovered

17%Died or euthanised

6 daysTypical onset

How soon it started

Same day

21 30%

1–2 days

10 14%

3–7 days

6 8.5%

1–4 weeks

10 14%

Over a month

24 34%

How the animals did

Recovered

11 13%

Still unwell when reported

40 48%

Died

5 6.0%

Euthanised

9 11%

Not known

19 23%

Problems reported at the same time

38 45%

36 43%

24 29%

14 17%

13 15%

12 14%

12 14%

10 12%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Lokivetmab controls allergic itch for 4–8 weeks per injection.

Products with this ingredient include Cytopoint. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Lokivetmab cause not himself/herself in dogs?: 84 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 6 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Not himself/herself with similar medicines

Not himself/herself after Bedinvetmab (Librela) 484 reports · 2.5% of its reports

All reported side effects of Lokivetmab in dogs · Medicines most reported with not himself/herself